Evanston, IL, United States of America

Chi-Hao Luan

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Northwestern University. Active years: 2023-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Chi-Hao Luan

Introduction

Chi-Hao Luan is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of biomedical research, particularly in the development of methods for treating infections caused by enveloped viruses. With a total of 2 patents, Luan's work is recognized for its potential impact on public health.

Latest Patents

Luan's latest patents include "HECT E3 UBIQUITIN LIGASE INHIBITORS AND USES THEREOF" and "Ilaprazole for inhibiting the release of enveloped viruses from cells." The latter patent discloses methods and compositions for treating infections by enveloped viruses in patients. These methods involve administering a compound that inhibits or blocks the release of the enveloped virus from infected cells. The disclosed methods may include administering a prazole-type compound featuring a substituted (pyridin-2-yl)methylsulfinyl-benzimidazole core.

Career Highlights

Chi-Hao Luan is affiliated with Northwestern University, where he conducts his research and development work. His innovative approaches have garnered attention in the scientific community, contributing to advancements in virology and therapeutic interventions.

Collaborations

Luan has collaborated with esteemed colleagues such as Jonathan Leis and Rama K Mishra, enhancing the scope and impact of his research endeavors.

Conclusion

Chi-Hao Luan's contributions to the field of biomedical research, particularly in the area of enveloped virus treatment, highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…